Home|DSIJArticleDetail

Upcoming collaboration: Two leading pharma company stocks to watch out for
Upcoming collaboration: Two leading pharma company stocks to watch out for

Upcoming collaboration: Two leading pharma company stocks to watch out for

US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns

DSIJ Intelligence-1 Article rating: 4.5

Upcoming collaboration: Two leading pharma company stocks to watch out for                                                                                                                                                                                            US FDA approved a benzyl alcohol and propylene glycol-free formulation to minimize gasping syndrome risk, for the treatment of seizures in newborns.

Multibagger Alert: Shares of this manufacturing company soared 1,767 per cent in just two years! Do you own this stock?
Multibagger Alert: Shares of this manufacturing company soared 1,767 per cent in just two years! Do you own this stock?

Multibagger Alert: Shares of this manufacturing company soared 1,767 per cent in just two years! Do you own this stock?

This multi-bagger stock has surged 135 per cent on a YTD basis and generated returns of 1,767 per cent in just two years! This means Rs 1 lakh invested in 2020 would have amounted to Rs 18.67 lakh today!! 

DSIJ Intelligence Article rating: 3.8

The shares of this company have made a fresh 52-week high at Rs 192.80 piece on September 16 (Friday).  

The stock has been hitting back-to-back upper circuits for a week and got locked in the 5 per cent upper circuit on Friday as well.  

DSIJ MINDSHARE

Mkt Commentary16-May, 2025

Swing Trading17-May, 2025

Penny Stocks17-May, 2025

Mindshare17-May, 2025

Mindshare17-May, 2025

Knowledge

MF15-May, 2025

MF2-May, 2025

MF30-Apr, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList